BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1594248)

  • 1. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of GAP and GAP-associated proteins in lymphoid and fibroblast cells expressing lck.
    Ellis C; Liu XQ; Anderson D; Abraham N; Veillette A; Pawson T
    Oncogene; 1991 Jun; 6(6):895-901. PubMed ID: 1906156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of tripartite chimeras between Src and Lck.
    Kashishian A; MacAuley A; Cooper JA
    Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two lck transcripts containing different 5' untranslated regions are present in T cells.
    Voronova AF; Adler HT; Sefton BM
    Mol Cell Biol; 1987 Dec; 7(12):4407-13. PubMed ID: 3501824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in expression of p56lck during myeloid differentiation of LSTRA cells.
    Garcia-Welsh A; Laskin DL; Molloy CJ; Laskin JD
    Cell Growth Differ; 1994 Nov; 5(11):1215-23. PubMed ID: 7531490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the activity and phosphorylation of the lck protein in lymphoid cells.
    Hurley TR; Sefton BM
    Oncogene; 1989 Mar; 4(3):265-72. PubMed ID: 2468122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters.
    Adler HT; Reynolds PJ; Kelley CM; Sefton BM
    J Virol; 1988 Nov; 62(11):4113-22. PubMed ID: 2845126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
    Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
    Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD4 associated tyrosine protein kinase p56lck is positively regulated through its site of autophosphorylation.
    Veillette A; Fournel M
    Oncogene; 1990 Oct; 5(10):1455-62. PubMed ID: 2250907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
    Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the enzymatic function of the lymphocyte-specific tyrosine protein kinase p56lck by the non-catalytic SH2 and SH3 domains.
    Veillette A; Caron L; Fournel M; Pawson T
    Oncogene; 1992 May; 7(5):971-80. PubMed ID: 1570157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
    Shin S; Steffen DL
    Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational activation of the lck proto-oncogene.
    Marth JD; Overell RW; Meier KE; Krebs EG; Perlmutter RM
    Nature; 1988 Mar; 332(6160):171-3. PubMed ID: 3347254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of a new tyrosine protein kinase is stimulated by retrovirus promoter insertion.
    Voronova AF; Sefton BM
    Nature; 1986 Feb 20-26; 319(6055):682-5. PubMed ID: 3081813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
    Rouer E; Benarous R
    Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redox regulation of a src family protein tyrosine kinase p56lck in T cells.
    Nakamura K; Hori T; Sato N; Sugie K; Kawakami T; Yodoi J
    Oncogene; 1993 Nov; 8(11):3133-9. PubMed ID: 8414515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.